{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 1.8404908, "regularMarketPrice": 83.0, "exchange": "STU", "shortName": "Krystal Biotech Inc.", "longName": "Krystal Biotech, Inc.", "messageBoardId": "finmb_534062888", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683886946, "earningsTimestamp": 1683548580, "earningsTimestampStart": 1691411400, "earningsTimestampEnd": 1691757000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -5.48, "sharesOutstanding": 25799700, "bookValue": 18.978, "fiftyDayAverage": 74.31, "fiftyDayAverageChange": 8.690002, "fiftyDayAverageChangePercent": 0.11694258, "twoHundredDayAverage": 72.6325, "twoHundredDayAverageChange": 10.3675, "twoHundredDayAverageChangePercent": 0.14273913, "marketCap": 2141375104, "priceToBook": 4.373485, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1541574000000, "priceHint": 2, "regularMarketChange": 1.5, "regularMarketDayHigh": 83.0, "regularMarketDayRange": "82.0 - 83.0", "regularMarketDayLow": 82.0, "regularMarketVolume": 7, "regularMarketPreviousClose": 81.5, "bid": 81.0, "ask": 82.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "financialCurrency": "USD", "regularMarketOpen": 82.0, "averageDailyVolume3Month": 112, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 35.8, "fiftyTwoWeekLowChangePercent": 0.7584745, "fiftyTwoWeekRange": "47.2 - 83.0", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "fiftyTwoWeekLow": 47.2, "fiftyTwoWeekHigh": 83.0, "symbol": "4KB.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2100 Wharton Street", "address2": "Suite 701", "city": "Pittsburgh", "state": "PA", "zip": "15203", "country": "United States", "phone": "412 586 5830", "website": "https://www.krystalbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 210, "companyOfficers": [{"maxAge": 1, "name": "Mr. Krish S. Krishnan M.B.A., M.S.", "age": 57, "title": "Founder, Chairman, Pres & CEO", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 1066831, "fmt": "1.07M", "longFmt": "1,066,831"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 5049, "fmt": "5.05k", "longFmt": "5,049"}}, {"maxAge": 1, "name": "Ms. Suma M. Krishnan", "age": 57, "title": "Founder, COO, Pres of R&D and Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 789923, "fmt": "789.92k", "longFmt": "789,923"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3515, "fmt": "3.52k", "longFmt": "3,515"}}, {"maxAge": 1, "name": "Ms. Kathryn A. Romano", "age": 40, "title": "Exec. VP & Chief Accounting Officer", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": {"raw": 528867, "fmt": "528.87k", "longFmt": "528,867"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 676426, "fmt": "676.43k", "longFmt": "676,426"}}, {"maxAge": 1, "name": "Dr. Andrew C. Orth", "age": 51, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 660533, "fmt": "660.53k", "longFmt": "660,533"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 716475, "fmt": "716.48k", "longFmt": "716,475"}}, {"maxAge": 1, "name": "Mr. Ram  Kamineni", "title": "Sr. VP of CMC & Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Meg  Dodge", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Glynn", "title": "Gen. Counsel, Commercial & Compliance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Karakkal", "title": "VP of North American Sales & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Josh  Suskin", "title": "Director of HR & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Hubert C. Chen M.D.", "age": 53, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}